Overview
Grifols, S.A. is a global healthcare company operating in the biotechnology and pharmaceutical industry, researching, developing, and producing plasma-derived medicines. These medicines treat rare, chronic diseases such as immune deficiencies and genetic emphysema. Grifols also provides hospital pharmacy products, diagnostic tools, and services for clinicians. Its key projects include the development of a potential treatment for Alzheimer's disease and producing a COVID-19 treatment using convalescent plasma. Grifols is committed to improving the health and well-being of people worldwide, and its innovative solutions continue to make it a leader in its industry.
AI+ Ask Fintel’s AI assistant about Grifols, S.A..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Grifols, S.A. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 679.77 MM |
| Earnings Date | |
| EPS (TTM) | 0.29 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-08-11 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.01 |
| ROE | 0.02 |
| ROIC | 0.01 |
| CROIC | 0.02 |
| OCROIC | 0.06 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 9.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Grifols, S.A.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-12-01 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2023-11-29 | ALANTRA EQUITIES | Buy | Buy | Maintains |
| 2023-11-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-07 | BERENBERG | Buy | Buy | Maintains |
| 2023-11-03 | ODDO BHF | Buy | Buy | Maintains |
| 2023-11-02 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-11-02 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-10-02 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2023-08-23 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2023-08-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-22 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2023-08-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-08-09 | ALANTRA EQUITIES | Buy | Buy | Maintains |
| 2023-08-08 | ALANTRA EQUITIES | Buy | Buy | Maintains |
| 2023-08-01 | EQUITA SIM | Hold | Hold | Maintains |
| 2023-07-31 | EQUITA SIM | Hold | Hold | Maintains |
| 2023-07-28 | ODDO BHF | Buy | Buy | Maintains |
| 2023-07-28 | BERENBERG | Buy | Buy | Maintains |
| 2023-07-27 | ODDO BHF | Buy | Buy | Maintains |
| 2023-07-27 | BERENBERG | Buy | Buy | Maintains |
| 2023-07-27 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2023-07-27 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-07-27 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-07-26 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2023-07-26 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-07-26 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-06-06 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2023-06-05 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2023-05-29 | BANCO SANTANDER | Buy | Outperform | Maintains |
| 2023-05-29 | ALANTRA EQUITIES | Neutral | Buy | Upgrade |
| 2023-05-29 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-05-28 | BANCO SANTANDER | Buy | Outperform | Maintains |
| 2023-05-28 | ALANTRA EQUITIES | Neutral | Buy | Upgrade |
| 2023-05-28 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-05-26 | BERENBERG | Buy | Buy | Maintains |
| 2023-05-25 | BERENBERG | Buy | Buy | Maintains |
| 2023-05-24 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-05-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-05-16 | EQUITA SIM | Hold | Hold | Maintains |
| 2023-05-15 | EQUITA SIM | Hold | Hold | Maintains |
| 2023-05-10 | ODDO BHF | Buy | Buy | Maintains |
| 2023-05-10 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-05-09 | ODDO BHF | Buy | Buy | Maintains |
| 2023-05-09 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-05-09 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-05-08 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-05-08 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2023-05-07 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2023-04-03 | CREDIT SUISSE - EUROPE | Outperform | Neutral | Downgrade |
| 2023-04-03 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2023-03-23 | BANCO SANTANDER | Buy | Outperform | Maintains |
| 2023-03-22 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-03-14 | EQUITA SIM | Hold | Hold | Maintains |
| 2023-03-01 | ODDO BHF | Buy | Buy | Maintains |
| 2023-03-01 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2023-03-01 | BERENBERG | Buy | Buy | Maintains |
| 2023-02-28 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-02-28 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2022-05-17 | ALANTRA EQUITIES | Neutral | Buy | Upgrade |
| 2022-05-16 | ALANTRA EQUITIES | Neutral | Buy | Upgrade |
| 2022-03-01 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2022-02-28 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2022-02-22 | HSBC | Hold | Buy | Upgrade |
| 2022-02-22 | HSBC | Buy | Buy | Maintains |
| 2022-02-21 | HSBC | Buy | Buy | Maintains |
| 2022-01-25 | ALANTRA EQUITIES | Strong Buy | Buy | Downgrade |
| 2022-01-24 | ALANTRA EQUITIES | Strong Buy | Buy | Downgrade |
| 2021-12-03 | BANCO SANTANDER | Buy | Buy | Maintains |
| 2021-12-02 | BANCO SANTANDER | Buy | Buy | Maintains |
| 2021-10-05 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2021-10-04 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2021-09-24 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2021-09-24 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2021-09-23 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2021-05-31 | ALANTRA EQUITIES | Strong Buy | Strong Buy | Maintains |
| 2021-05-30 | ALANTRA EQUITIES | Strong Buy | Strong Buy | Maintains |
| 2021-03-02 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2020-11-23 | HSBC | Hold | Hold | Maintains |
| 2019-10-28 | Santander | Hold | Buy | Upgrade |
| 2019-06-27 | JP Morgan | Neutral | Overweight | Upgrade |
| 2019-02-08 | Berenberg | Buy | Hold | Downgrade |
| 2019-01-02 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-10-01 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2018-03-01 | Morgan Stanley | Underweight | Underweight | Maintains |
| 2016-03-17 | Nomura | Buy | Initiate | |
| 2016-02-09 | Berenberg | Hold | Buy | Upgrade |
| 2016-01-04 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
| 2015-12-02 | HSBC | Buy | Hold | Downgrade |
| 2015-11-20 | Berenberg | Buy | Hold | Downgrade |
| 2015-02-12 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2014-03-04 | JP Morgan | Neutral | Overweight | Maintains |
| 2024-08-01 | BERENBERG | Buy | Buy | Maintains |
| 2024-07-30 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2024-07-30 | ALANTRA EQUITIES | Buy | Neutral | Downgrade |
| 2024-07-29 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2024-07-23 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-07-07 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2024-03-27 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-11-21 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-06 | BERENBERG | Buy | Buy | Maintains |
| 2024-02-29 | ALANTRA EQUITIES | Buy | Buy | Maintains |
| 2024-02-28 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-12-28 | ODDO BHF | Buy | Buy | Maintains |
| 2023-11-30 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2023-11-28 | ALANTRA EQUITIES | Buy | Buy | Maintains |
| 2023-11-02 | ODDO BHF | Buy | Buy | Maintains |
| 2023-11-01 | ANALISIS BANCO SABADELL | Buy | Buy | Maintains |
| 2023-11-01 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2023-10-01 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2024-12-18 | ALANTRA EQUITIES | Neutral | Neutral | Maintains |
| 2024-12-17 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2024-12-15 | BERENBERG | Buy | Buy | Maintains |
| 2024-11-07 | ANALISIS BANCO SABADELL | Buy | Overweight | Maintains |
| 2024-09-22 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2024-09-04 | MIRABAUD SECURITIES | Buy | Buy | Maintains |
| 2025-04-01 | ALANTRA EQUITIES | Neutral | Neutral | Maintains |
| 2025-03-30 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2025-03-04 | BERENBERG | Buy | Buy | Maintains |
| 2025-02-26 | ANALISIS BANCO SABADELL | Overweight | Overweight | Maintains |
| 2025-02-25 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2025-07-09 | BANCO SANTANDER | Outperform | Outperform | Maintains |
| 2025-06-29 | CAIXABANK BPI | Buy | Buy | Maintains |
| 2025-06-23 | ALANTRA EQUITIES | Neutral | Neutral | Maintains |
| 2025-05-12 | ANALISIS BANCO SABADELL | Overweight | Overweight | Maintains |
